A commentary on Diagnosing Cushing's disease in the context of renal failure

Hershel Raff1, Eric P Cohen2, James W Findling3

  • 1Departments of Medicine, Surgery, and Physiology, Medical College of Wisconsin and Endocrine Research Laboratory, Aurora St Luke's Medical Center, Aurora Research Institute, Milwaukee, Wisconsin, USA.

Insights

Diagnosing Cushing's syndrome is difficult, especially with chronic kidney disease (CKD). Late-night salivary cortisol (LNSC) testing is a reliable diagnostic tool, even when urine free cortisol (UFC) is not useful in CKD patients.

Area of Science:

  • Endocrinology
  • Nephrology
  • Diagnostic Medicine

Background:

  • Endogenous hypercortisolism (Cushing's syndrome) diagnosis presents significant challenges.
  • Chronic kidney disease (CKD) complicates diagnosis by altering the hypothalamic-pituitary-adrenal axis.
  • Standard urine free cortisol (UFC) testing is unreliable in patients with CKD.

Purpose of the Study:

  • To highlight the diagnostic challenges of Cushing's syndrome in patients with CKD.
  • To emphasize the utility of late-night salivary cortisol (LNSC) testing in this population.
  • To present a case illustrating the effectiveness of LNSC in diagnosing ACTH-dependent Cushing's syndrome.

Main Methods:

  • Case report analysis of a patient with pituitary ACTH-dependent Cushing's syndrome and CKD.
  • Comparison of diagnostic test results, including UFC and LNSC.
  • Evaluation of treatment outcomes following pituitary adenomectomy.

Main Results:

  • The patient presented with normal UFC levels, masking the diagnosis of Cushing's syndrome.
  • Elevated LNSC levels were diagnostic for ACTH-dependent Cushing's syndrome.
  • Pituitary adenomectomy resulted in a curative outcome.

Conclusions:

  • Late-night salivary cortisol (LNSC) measurement is the preferred diagnostic test for suspected Cushing's syndrome.
  • LNSC is particularly valuable in patients with CKD where UFC is unreliable.
  • Accurate diagnosis and timely treatment, such as surgery, are crucial for managing Cushing's syndrome.

Related Concept Videos

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...